KNIGHT JEFF E. (Chief Operating Officer) received a stock award from CRINETICS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/25/2026ACC: 0001628280-26-011723
Officer· Chief Operating Officer
Since Aug 2021
+89K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
89K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+34K
Price / share
—
Trade value
—
% of position
38.7%
2/23/2026
87.93K→121.93K
Total
Net shares
+34K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/23/2026 | A · Award | +34K | — | — | 38.7% | 87.93K | 121.93K |
| Total | +34K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
55K shares
Shares
+55K
Strike price
43.79
Held after
55K
Exercisable
—
2/23/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock55K shares | 2/23/2026 | A · Award | +55K | 43.79 | — | 55K |